Animal Toxoplasmosis

Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.

Also Known As:

Toxoplasmosis, Animal; Animal Toxoplasmoses; Toxoplasmoses, Animal

Networked: 11 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Infections: 526564
- Parasitic Diseases: 4870
  - Protozoan Infections: 282
    - Coccidiosis: 1332
      - Toxoplasmosis: 4477
        Animal Toxoplasmosis: 11
    - Animal Protozoan Infections
      - Animal Toxoplasmosis: 11
  - Animal Parasitic Diseases: 2
    - Animal Protozoan Infections
      - Animal Toxoplasmosis: 11
Animal Diseases: 416
- Animal Parasitic Diseases: 2
  - Animal Protozoan Infections
    - Animal Toxoplasmosis: 11

Related Diseases

1.	Infections
2.	Pseudorabies

Experts

1.	Długońska, Henryka: 3 articles (12/2015 - 09/2014)
2.	Grzybowski, Marcin M: 3 articles (12/2015 - 09/2014)
3.	Dziadek, Bożena: 2 articles (12/2015 - 03/2015)
4.	Dzitko, Katarzyna: 2 articles (12/2015 - 03/2015)
5.	Gatkowska, Justyna M: 2 articles (12/2015 - 09/2014)
6.	Hajissa, Khalid: 1 article (04/2018)
7.	Mohamed, Zeehaida: 1 article (04/2018)
8.	Suppian, Rapeah: 1 article (04/2018)
9.	Zakaria, Robaiza: 1 article (04/2018)
10.	Dziadek, Jarosław: 1 article (03/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Animal Toxoplasmosis:

1.	AntigensIBA 07/01/1963 - "Allergic skin reactions were produced in the experimental animals but improvement in the antigen is necessary before the test could be used generally in the field as a diagnostic method for animal toxoplasmosis." 04/01/2018 - "The proven immunogenicity of the generated antigen can serve as a premise for further use of epitope-based vaccine in the immunoprevention of human and animal toxoplasmosis."
2.	VaccinesIBA 12/01/2015 - "An effective vaccine against human and animal toxoplasmosis is still needed to control this parasitosis. " 09/01/2014 - "With one exception (Toxovax for sheep), there are no vaccines to prevent human or animal toxoplasmosis. " 09/01/1994 - "The emergence of Toxoplasma gondii as a major opportunistic organism in immunocompromised individuals and the steady increase in economic losses due to animal toxoplasmosis have fuelled the interest in vaccine development. " 03/01/2015 - "The proven immunoreactivity of the obtained preparations has become a premise for a further study on their utility in routine diagnosis of human and animal toxoplasmosis as well as in the immunoprevention of T. gondii infection (as the main or supplementary component of the vaccine). " 10/01/2008 - "gondii in PRV Bartha K-61 is a novel approach towards the development of a vaccine against both animal toxoplasmosis and pseudorabies."
3.	Complement System Proteins (Complement)IBA 01/01/1961 - "[Studies on the animal toxoplasmosis reservoir by means of the complement fixation test]."
4.	Proteins (Proteins, Gene)FDA Link 01/01/2022 - "Application of Toxoplasma gondii-specific SAG1, GRA7 and BAG1 proteins in serodiagnosis of animal toxoplasmosis."
5.	EpitopesIBA 04/01/2018 - "The proven immunogenicity of the generated antigen can serve as a premise for further use of epitope-based vaccine in the immunoprevention of human and animal toxoplasmosis."
6.	AntibodiesIBA 12/01/1970 - "[Incomplete antibodies in animal toxoplasmosis]."
7.	sulfachlorpyrazineIBA 01/01/2012 - "It can be concluded that the effective drug sulfachloropyrazine may be the new therapeutic options against animal toxoplasmosis."